PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 219 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $253,000 | +15.0% | 5,577 | +10.4% | 0.02% | -8.3% |
| Q2 2019 | $220,000 | -7.9% | 5,053 | -9.0% | 0.02% | -29.4% |
| Q4 2018 | $239,000 | -24.6% | 5,550 | -13.7% | 0.03% | -10.5% |
| Q3 2018 | $317,000 | +51.0% | 6,430 | -1.8% | 0.04% | +35.7% |
| Q2 2018 | $210,000 | -99.8% | 6,547 | +340.9% | 0.03% | -12.5% |
| Q2 2014 | $136,412,000 | – | 1,485 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |